
News|Articles|December 8, 2015
Role of the Pharmacist in ACS Management with Platelet Aggregation Inhibitors
Andrew North, PharmD, BCPS, a specialty practice pharmacist in emergency medicine at the Ohio State University Wexner Medical Center, discusses the pharmacist's role in acute coronary syndrome management with platelet aggregation inhibitors.
Advertisement
Andrew North, PharmD, BCPS, a specialty practice pharmacist in emergency medicine at the Ohio State University Wexner Medical Center, discusses the pharmacist’s role in acute coronary syndrome management with platelet aggregation inhibitors.
This video was recorded at the 2015 American Society of Health-System Pharmacists Midyear Meeting.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Tradipitant Becomes First Treatment Approved for Vomiting Due to Motion Sickness in 4 Decades
2
Aspirin Dosage and Decision-Making: What Pharmacists Should Know
3
FDA May Relax Dietary Supplement Warning Label Rules: Implications for Public Health
4
New Drug Approach Targets KRAS-Mutant Lung Cancer to Overcome Therapy Resistance
5












































































































































































































